| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 49,571 | 34,635 | 33,232 | 33,472 | | Cost of Revenue | 37,092 | 24,788 | 21,337 | 22,131 | | | Gross Profit | 12,479 | 9,847 | 11,895 | 11,341 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,619 | 8,096 | 9,699 | 8,703 | | Non Recurring | 30 | (30) | (25) | (21) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,830 | 1,781 | 2,221 | 2,659 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 323 | 545 | 792 | 1,284 | | Earnings Before Interest And Taxes | 3,118 | 2,326 | 3,013 | 3,943 | | Interest Expense | (20) | 20 |
-
|
-
| | Income Before Tax | 3,138 | 2,306 | 3,013 | 3,943 | | Income Tax Expense | 1,069 | 784 | 1,370 | 1,337 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,069 | 1,522 | 1,643 | 2,606 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,069 | 1,522 | 1,643 | 2,606 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,069 | $1,522 | $1,643 | $2,606 |
|
0.16% Nasdaq 
0.07%
Income Statement
